← Back to Search

Non-invasive Brain Stimulation

Unipolar Depression for Depression

N/A
Waitlist Available
Led By Joan Camprodon, MD, PhD, MPH
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
DSM-IV diagnosis of Depressive Episode
Patients requiring TMS treatment as part of their psychiatric care
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through treatment completion, average of 6 weeks
Awards & highlights

Study Summary

This trial looked at the effects of TMS on the brains of patients with unipolar depression.

Who is the study for?
This trial is for men and women aged 18-80 with a diagnosis of depression who need Transcranial Magnetic Stimulation (TMS) as part of their psychiatric care. It's not suitable for those with MRI contraindications, other primary mental health conditions like schizophrenia, active substance abuse in the past 3 months, or severe medical illnesses.Check my eligibility
What is being tested?
The study observes how TMS affects the brain in patients with unipolar depression. This non-invasive treatment uses magnetic fields to stimulate nerve cells in the brain and is being studied using neuroimaging techniques.See study design
What are the potential side effects?
While this observational study focuses on imaging results rather than side effects, TMS can sometimes cause headaches, scalp discomfort at the site of stimulation, tingling or spasms of facial muscles, lightheadedness or seizures (rare).

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with depression.
Select...
I need TMS treatment for my mental health condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through treatment completion, average of 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and through treatment completion, average of 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in Functional Connectivity of Key Nodes in Depression

Trial Design

1Treatment groups
Experimental Treatment
Group I: Unipolar DepressionExperimental Treatment1 Intervention
Patients diagnosed with unipolar depression.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Magnetic Stimulation
2011
Completed Phase 4
~710

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,918 Previous Clinical Trials
13,192,781 Total Patients Enrolled
182 Trials studying Depression
29,366 Patients Enrolled for Depression
Joan Camprodon, MD, PhD, MPHPrincipal InvestigatorMassachusetts General Hospital
5 Previous Clinical Trials
930 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently being sought out for involvement in this research?

"As per the clinicaltrials.gov records, this medical trial has ceased to recruit participants as of October 3rd 2022. Initially posted on November 1st 2011, it is one of 1297 studies actively looking for patients at present time."

Answered by AI

Does this experiment encompass participants that are octogenarian?

"This investigation is open to adults aged 18 and above, yet below 80 years of age."

Answered by AI

Might I be eligible to join this experiment?

"The medical trial is searching to recruit 54 eligible people with depression and ages ranging from 18 to 80."

Answered by AI
~4 spots leftby Apr 2025